Get started
Author

Kiyotoshi Mori

Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling
2002 · Masahiro Yamamoto, Shintaro Sato, et al. · The Journal of Immunology · 1,251
PDF
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
2020 · Ayumi Kaneda, Toshihiro Seike, et al. · American Journal of Cancer Research · 136
Purification and Characterization of a Src-related p57 Protein-tyrosine Kinase from Xenopus Oocytes
1996 · Ken-ichi Sato, Mamoru Aoto, et al. · Journal of Biological Chemistry · 77
PDF
The Noncompetitive Antagonism of Histamine H1 Receptors Expressed in Chinese Hamster Ovary Cells by Olopatadine Hydrochloride: Its Potency and Molecular Mechanism
2008 · Yuichi Matsumoto, Jun Funahashi, et al. · Pharmacology · 16
Biochemical evidence for the interaction of regulatory subunit of cAMP‐dependent protein kinase with IDA (Inter‐DFG‐APE) region of catalytic subunit
1996 · Setsuko Sahara, Ken-ichi Sato, et al. · FEBS Letters · 14
PDF
K-685, a TRPV1 Antagonist, Blocks PKC-Sensitized TRPV1 Activation and Improves the Inflammatory Pain in a Rat Complete Freund’s Adjuvant Model
2013 · Yoshiyuki Sugimoto, Yozo Kojima, et al. · Journal of Pharmacological Sciences · 12
PDF
A novel mouse model of cutaneous T‐cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy
2022 · Keiko Nakahashi, Kaito Nihira, et al. · Experimental Dermatology · 4
PDF
The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti‐ PD ‐1 antibody and paclitaxel
2024 · Chiaki Kobayashi, Minami Suzuki‐Imaizumi, et al. · Cancer Science · 3
PDF
Development and Efficacy of a Novel Bromodomain and Extraterminal Domain Degrader K-256 in MYC/BCL2-Related Lymphoma
2023 · Kastuya Furukawa, Kazuyuki Shimada, et al. · Blood · 3
PDF
Glucose concentration-dependent potentiation of insulin secretion by a new chemical entity, KCP256
2005 · Kiyotoshi Mori, Kotaro Takasaki, et al. · European Journal of Pharmacology · 1
Abstract 2913: Entinostat (KHK2375), class I histone deacetylase inhibitor, regulates human Treg function by decreasing Foxp3 expression and effector Treg population
2020 · Hiromichi Kosaka, Yozo Nishimura, et al. · Cancer Research
In Vitro and In Vivo Characterization of KHK2455, a novel, Highly Potent and Selective Indoleamine 2,3-dioxygenase 1 (IDO1) Inhibitor
2018 · Motoya Mie, Kunieda Kana, et al.
Works count: 12
Citation count: 1,517
H-index: 6
I10-index: 6
Year
Topic
Type